Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced significant progress in its development efforts to treat the underlying cause of cystic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE